Shenkang injection for the treatment of acute kidney injury: a systematic review and meta-analysis

References

• Sato Y, Yanagita M. Immune cells and inflammation in AKI to CKD progression. Am J Physiol Renal Physiol. 2018;315(6):1–16. doi: 10.1152/ajprenal.00195.2018. Epub 2018 Aug 29.
   Web of Science ®Google Scholar
• Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis. 2018;72(1):136–148. doi: 10.1053/j.ajkd.2017.11.021.
   PubMed Web of Science ®Google Scholar
• Matuszkiewicz-Rowińska J, Małyszko J. Acute kidney injury, its definition, and treatment in adults: guidelines and reality. Pol Arch Intern Med. 2020;130(12):1074–1080. doi: 10.20452/pamw.15373.
   PubMedGoogle Scholar
• Kidney Disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Kdigo clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138. doi: 10.1038/kisup.2012.1.
   Web of Science ®Google Scholar
• Chawla LS, Bellomo R, Bihorac A, Acute Disease Quality Initiative Workgroup 16., et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–257. doi: 10.1038/nrneph.2017.2.
   PubMed Web of Science ®Google Scholar
• Liu KD, Goldstein SL, Vijayan A, AKI!Now Initiative of the American Society of Nephrology., et al. AKI!now initiative: recommendations for awareness, recognition, and management of AKI. Clin J Am Soc Nephrol. 2020;15(12):1838–1847. doi: 10.2215/CJN.15611219.
   PubMed Web of Science ®Google Scholar
• Vijayan A. Tackling AKI: prevention, timing of dialysis and follow-up. Nat Rev Nephrol. 2021 ;17(2):87–88. doi: 10.1038/s41581-020-00390-3.
   PubMed Web of Science ®Google Scholar
• Rui Y, Li S, Luan F, et al. Several alkaloids in Chinese herbal medicine exert protection in acute kidney injury: focus on mechanism and target analysis. Oxid Med Cell Longev. 2022;2022:2427802–2427816. doi: 10.1155/2022/2427802.
   PubMed Web of Science ®Google Scholar
• Li HD, Meng XM, Huang C, et al. Application of herbal traditional Chinese medicine in the treatment of acute kidney injury. Front Pharmacol. 201910:376. doi: 10.3389/fphar.2019.00376.
   PubMed Web of Science ®Google Scholar
• Chen XM, Li P, Sun XF, et al. Expert consensus on the rational application of Shenkang preparations (Shenkang injection, Shenkang suppository) in the treatment of chronic kidney disease. Chin. J. Integr. Tradit. West. Med. (Chin. Ed.). 2019;39(7):784–786. doi: 10.7661/j.cjim.20190520.017.
   Google Scholar
• Ye N, Xie D, Yang B, et al. The mechanisms of the herbal components of CRSAS on HK-2 cells in a hypoxia/reoxygenation model based on network pharmacology. Evid Based Complement Alternat Med. 2020;2020:5352490–5352410. doi: 10.1155/2020/5352490.
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
   PubMed Web of Science ®Google Scholar
• Ronco C, Levin A, Warnock DG, AKIN Working Group., et al. Improving outcomes from acute kidney injury (AKI): report on an initiative. Int J Artif Organs. 2007;30(5):373–376. doi: 10.1053/j.ajkd.2007.05.008.
   PubMed Web of Science ®Google Scholar
• Thomas J, Chandler J, Miranda C, JPT, H. J., et al. 2019). Cochrane Handbook for Systematic Reviews of Interven­tions version 6.0.Cochrane. Available from www.training.cochrane.org/handbook.
   Google Scholar
• Nie WQ, Yu XQ, Wang LM, et al. Clinical research on Shenkang injection in the treatment. Pharmacol. Clin. Chin. Mater. Med. 2014;30(01):136–139. doi: 10.13412/j.cnki.zyyl.2014.01.043.
   Google Scholar
• Song GL, Wang FY, Tan XH, et al. Study on the treatment of multiple organ insufficiency with acute kidney injury in the elderly with Shenkang injection. J. Med. Inf. 2014 Aug;27(8):272. doi: 10.3969/j.issn.1006-1959.2014.22.300.
   Google Scholar
• Shi QK, Zhang C, Niu YS. The efficacy of Shenkang injection in treating early acute kidney injury after coronary artery bypass grafting surgery. Mod. J. Integr. Tradit. Chin. West. Med. 2016 Feb;25(04):391–393. doi: 10.3969/j.issn.1008-8849.2016.04.016.
   Google Scholar
• Jia SL. Therapeutic effect of Shenkang injection combined with calcium dobesilate capsules on primary nephritic syndrome complicated with acute kidney injury and its influence on coagulation fibrinolysis system. Mod. J. Integr. Tradit. Chin. West. Med. 2017;26(27):2976–2979 + 2995. doi: 10.3969/j.issn.1008-8849.2017.27.004.
   Google Scholar
• Liu H, Liu CL, Lu JF, et al. Intervention of Shenkang injection combined with simvastatin on oxidative stress indicators in patients with acute kidney injury. J. Hebei. N.A. University. (Nat. Sci. Edit.). 2017;33(06):13–15.
   Google Scholar
• Wang LM, Yu XQ, Nie WQ, et al. Clinical observation on Shenkang injection in the treatment of patients with acute kidney injury induced by sepsis. Clinical. J. Traditional. Chin. Med. 2017 Jul;29(07):1068–1071. doi: 10.16448/j.cjtcm.2017.0358.
   Google Scholar
• Gao SP, Cao L. Clinical observation of Shenkang injection in the treatment of acute kidney injury. China Pharm. 2020;29(24):87–88. doi: 10.3969/j.issn.1006－4931.2020.24.028.
   Google Scholar
• Li JZ, Lu YP. Study on the therapeutic effect of Shenkang injection on acute renal injury. Med. Innovation China. 2020;17(14):57–60. doi: 10.3969/j.issn.1674-4985.2020.14.014.
   Google Scholar
• Wang J, He WB, Ren BH. Clinical study of Shenkang injection combined with calcium hydroxybenzenesulfonate capsule in the treatment of primary nephrotic syndrome complicated with acute kidney injury. J. Jinzhou Med. Univ. 2020;41(06):64–67. doi: 10.13847/j.cnki.lnmu.2020.06.014.
   Google Scholar
• Zhang CL, Wang CL, Xie HD, et al. Shenkang injection on inflammatory response in patients with acute kidney injury and renal function in patients with acute kidney injury. Beijing. J. Traditional. Chin. Med. 2020;39(05):483–486. doi: 10.16025/j.1674-1307.2020.05.022.
   Google Scholar
• Chen L, Huang J, Chen YJ, et al. Effect of Shenkang injection combined with calcium dobesilate capsule on renal function, coagulation function and inflammatory factors in patients with PNS complicated with AKI. Prog. Mod. Biomed. 2021;21(08):1456–1459 + 1419. doi: 10.13241/j.cnki.pmb.2021.08.012.
   Google Scholar
• Wang Q, Gong XZ. Discussion on traditional Chinese medicine pathogenesis and treatment of acute kidney injury. J. Chengdu. University. TCM. 2013;36(04):107–109 + 111. doi: 10.13593/j.cnki.51-1501/r.2013.04.034.
   Google Scholar
• Xie F, Zhang T, Zhang P, et al. Shenkang injection combined with alprostadil for chronic renal failure: a systematic review and meta-analysis. Front Med (Lausanne). 2023;10:982016. doi: 10.3389/fmed.2023.982016.
   PubMed Web of Science ®Google Scholar
• Su J, He T, You J, et al. Therapeutic effect and underlying mechanism of shenkang injection against cisplatin-induced acute kidney injury in mice. J Ethnopharmacol. 2023;301:115805. doi: 10.1016/j.jep.2022.115805. Epub 2022 Oct 7.
   Google Scholar